Development and validation of characterization methods for Lipidots® Multifunctional Platform: a step towards industrial transfer

Lipidots® technology has thrived towards a versatile nanodelivery platform for designing and producing a series of nanoproducts for in vivo diagnostic, in vivo imaging, activated or non-activated targeted drug delivery. In order to ensure quality of final products, characterization as nanotherapeutics is a key parameter. Thus, we are seeking to implement and validate a panel of characterization methods significantly suitable for Lipidots®. More particularly, we have investigated the lipid quantification, the drug/dye encapsulation, release kinetics and leakage to anticipate the nanocarrier behavior in biological media.